Argos Therapeutics

Research Triangle Park, NC

CEO: Jeff Abbey

Ticker: Nasdaq: ARGS

Argos Therapeutics is an immunotherapy company developing new treatments for cancer, infectious and autoimmune diseases and transplantation rejection. The company has generated multiple platform technologies and a diverse pipeline of products based on its expertise in the biology of dendritic cells – the master switch that turns the immune system on or off.